AMELA THOMPSON: Open Payments
NPI 1003543711 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,719 in 128 payments from 21 companies in 2025. Trend: 2023 $2,235 · 2024 $2,829 · 2025 $2,719
Food & beverage: $2,719
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $749 |
| AstraZeneca Pharmaceuticals LP | 14 | $293 |
| PFIZER INC. | 13 | $239 |
| Amgen Inc. | 15 | $208 |
| Novo Nordisk Inc | 4 | $189 |
| Lilly USA, LLC | 9 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Merck Sharp & Dohme LLC | 5 | $111 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Astellas Pharma US Inc | 4 | $98 |
Products named: QULIPTA, VRAYLAR, NURTEC ODT, Ozempic, BREZTRI, OTEZLA, CAPLYTA, JARDIANCE.
Industry payments across NY — which companies pay providers there.
